FDA Clears Quoin Pharmaceuticals to Employ Teens for Netherton Syndrome Clinical Trials

Teens to be included in both placebo and open label studies for QRX003, a potential treatment for Netherton syndrome.

Source link
#FDA #Clears #Quoin #Pharmaceuticals #Employ #Teens #Netherton #Syndrome #Clinical #Trials